|
Mar 18
|
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
|
|
Mar 14
|
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
|
|
Mar 12
|
Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...
|
|
Mar 7
|
Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results
|
|
Mar 7
|
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Aquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Mar 7
|
Q4 2023 Aquestive Therapeutics Inc Earnings Call
|
|
Mar 5
|
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 5
|
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
|
|
Mar 4
|
Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?
|
|
Feb 29
|
Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know
|
|
Jan 30
|
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
|
|
Jan 26
|
Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jan 23
|
Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade
|
|
Jan 18
|
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) top owners are individual investors with 60% stake, while 27% is held by institutions
|
|
Jan 17
|
Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors
|
|
Jan 11
|
Here's Why Aquestive Therapeutics (AQST) Fell More Than Broader Market
|
|
Dec 27
|
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
|
|
Dec 26
|
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?
|
|
Dec 7
|
Best Momentum Stock to Buy for December 7th
|